However, an enhanced effect was observed in mice treated with the double-promoter construct H19-DTA-P4-DTA, wherein tumor development was inhibited by nearly 70% (P = 0.005) compared to mice treated with the control plasmid H19-Luc-P4-Luc. This evidence concerns the gene H19 and neoplasm.